A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.
Patients with HIV had similar treatment outcomes to patients without HIV when treated for mpox with an antiviral drug called tecovirimat, according to a new study.
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Two Cornell faculty members have been named Freeman Hrabowski Scholars by the Howard Hughes Medical Institute, in recognition of their potential to become leaders in their research fields and to create diverse and inclusive lab environments.
More research and oversight are needed before making permanent a pandemic policy that allows hospitals to treat acutely ill patients in their homes, according to new Cornell research.
In a first-of-its-kind analysis, Cornell researchers and partners at the Clinton Health Access Initiative found that pharmaceutical producers could reduce their environmental impact by roughly half by optimizing manufacturing processes and supply chain networks and by switching to renewable energy sources.
As the world population grows and climate change threatens agriculture and global food systems, researchers across Cornell CALS are reimagining agri-food systems for the 21st century.
